Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma

Han, KelongRen, MelanieWick, WolfgangAbrey, LaurenDas, AshaJin, JinReardon, David2015-05-042015Han, Kelong, Melanie Ren, Wolfgang Wick, Lauren Abrey, Asha Das, Jin Jin, and David A. Reardon. 2015. “Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma.” Neuro-Oncology 17 (5): 764-765. doi:10.1093/neuonc/nov021. http://dx.doi.org/10.1093/neuonc/nov021.1522-8517http://nrs.harvard.edu/urn-3:HUL.InstRepos:15035025en-USInterpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastomaJournal Article2015-05-0410.1093/neuonc/nov021